Tackling the scar tissue that shields pancreatic tumours from effective drug access is a promising advance in a notoriously hard-to-treat cancer.
Hepatitis C testing and treatment in prisons is key to reducing infections, a new study by the Kirby Institute has shown.
What is the difference between the mRNA vaccine and the adenovirus vaccine? Can the mRNA vaccine be tweaked when new variants develop?
UNSW researchers say implementation of new fall prevention strategies will have real impact on lives
NSW is developing a planning policy with the goal of creating healthy places. The policy goals need to be embedded in laws and budgets.
Skyrocketing demand coupled with shortages of vital components is leading to bottlenecks in the supply chain of Pfizer's and other mRNA vaccines.
During the height of the pandemic, people with disability felt they had been forgotten and were not a priority. In the vaccine rollout, the government is repeating its past mistakes.
With over 139 million COVID-19 cases globally, the latest challenge for medical researchers is a post-COVID-19 syndrome referred to as 'long COVID'.
Last week, thousands tuned in online to hear guest speaker Dr Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases at the US National Institutes of Health.
The health benefits of intergenerational activity, such as reducing frailty, will be assessed by UNSW researchers.